The Japanese Ministry of Health, Labour and Welfare recently approved Zolgensma, Novartis' gene therapy drug for the treatment of spinal muscular atrophy, for infants under the age of 2, according to Medical Dialogues.
The Latest
Speaking about the spread of the novel coronavirus in a March 23 interview on NBC's Today, U.S. Surgeon General Jerome Adams, MD, warned Americans that "this week, it's going to get bad."
The trial for a Santa Rosa, Calif.-based neurosurgeon accused of causing four patient deaths by overprescribing opioids concluded March 20, The Press Democrat reports.
Dusty Richardson, MD, a neurosurgeon at Billings (Mont.) Clinic and dentist Spencer Zaugg, DDS, have developed a durable, reusable plastic mask using 3D printer technology.
On March 18, Medtronic pledged to increase production of ventilators that are in short supply for treating COVID-19 patients. The company has connected with Tesla CEO Elon Musk about the ramp up.
On March 19, Chicago-based Midwest Orthopaedics at Rush implemented new policies around patient visits and performing surgeries through mid-April due to the coronavirus outbreak. The time-line is subject to change based upon the nature of the demands on the local…
Fairchild Medical Center in Yreka, Calif., suspended elective orthopedic surgeries to prevent the spread of the novel coronavirus, reports The Siskiyou Daily.
Medicrea is taking steps to weather the COVID-19 pandemic, the spinal surgery technology provider informed shareholders March 20.
Two emergency room physicians at Rush Oak Park (Ill.) Hospital tested positive for COVID-19 and immediately went into quarantine, OakPark.com reports.
COVID-19 testing in the U.S. lags behind other countries, except when it comes to the NBA, where the league has been testing players with ease, SBNation reports.